{"id":"https://openalex.org/W2474733232","doi":null,"title":"Lamivudine therapy for children with chronic hepatitis B infection","display_name":"Lamivudine therapy for children with chronic hepatitis B infection","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2474733232","mag":"2474733232"},"language":"en","primary_location":{"id":"mag:2474733232","doi":null,"is_oa":false,"landing_page_url":"https://www.journal-of-hepatology.eu/article/S0168-8278(03)00046-1/pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018974631","display_name":"Guadalupe Garc\u00eda\u2013Tsao","orcid":"https://orcid.org/0000-0002-6175-8216","observed_orcids":["https://orcid.org/0000-0002-6175-8216","https://orcid.org/0000-0001-8371-4524"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guadalupe Garc\u00eda\u2010Tsao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6175-8216","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044314042","display_name":"Ronald P.J. Oude Elferink","orcid":"https://orcid.org/0000-0002-1779-0833","observed_orcids":["https://orcid.org/0000-0002-1779-0833"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald Oude Elferink","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048480496","display_name":"James Lorenzen Boyer","orcid":"https://orcid.org/0000-0002-8959-6036","observed_orcids":["https://orcid.org/0000-0002-8959-6036"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James L. Boyer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8959-6036","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087156903","display_name":"Hartmut Jaeschke","orcid":"https://orcid.org/0000-0002-8695-6980","observed_orcids":["https://orcid.org/0000-0002-8695-6980"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hartmut Jaeschke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8695-6980","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111635906","display_name":"Luigi Pagliaro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigi Pagliaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058586466","display_name":"Jorge Rakela","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Rakela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067200658","display_name":"Tania Roskams","orcid":"https://orcid.org/0000-0002-2816-1530","observed_orcids":["https://orcid.org/0000-0002-2816-1530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tania Roskams","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2816-1530","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006242340","display_name":"Christian Trautwein","orcid":"https://orcid.org/0000-0003-2762-8247","observed_orcids":["https://orcid.org/0000-0003-2762-8247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Trautwein","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2762-8247","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113634112","display_name":"Jacek Mizerski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Mizerski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012147350","display_name":"Badia Ib","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Badia Ib","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33378249,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10337","display_name":"Liver Disease and Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":1.0},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.7170000076293945},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/virological-response","display_name":"virological response","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hbv-dna-suppression","display_name":"HBV DNA suppression","score":0.7870000004768372},{"id":"https://openalex.org/keywords/hbeag","display_name":"HBeAg","score":0.7960000038146973},{"id":"https://openalex.org/keywords/seroconversion","display_name":"seroconversion","score":0.9200000166893005},{"id":"https://openalex.org/keywords/alanine-aminotransferase-normalization","display_name":"alanine aminotransferase normalization","score":0.9629999995231628},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.9631043672561646},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8126158118247986},{"id":"https://openalex.org/C2777451964","wikidata":"https://www.wikidata.org/wiki/Q2141450","display_name":"Seroconversion","level":3,"score":0.7222774028778076},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6102949380874634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6036792993545532},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5503496527671814},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5373119115829468},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.502784013748169},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.4511401951313019},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44047537446022034},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2215968370437622},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.21728578209877014},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.12899690866470337},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06370872259140015},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2474733232","doi":null,"is_oa":false,"landing_page_url":"https://www.journal-of-hepatology.eu/article/S0168-8278(03)00046-1/pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1980961129","https://openalex.org/W2071167068","https://openalex.org/W2137544368"],"related_works":["https://openalex.org/W2071167068","https://openalex.org/W2386524684","https://openalex.org/W2418043455","https://openalex.org/W20572182","https://openalex.org/W2082711849","https://openalex.org/W2524116562","https://openalex.org/W2359440332","https://openalex.org/W2105823091","https://openalex.org/W2387480374","https://openalex.org/W2005277828"],"abstract_inverted_index":{"Lamivudine":[0,138],"therapy":[1,139],"is":[2],"effective":[3],"for":[4,22,63],"chronic":[5,23,34,175],"hepatitis":[6,26,35,79,153,158,176],"B":[7,27,36,80,154,159],"infection":[8,24],"in":[9,30,40],"adults.":[10],"We":[11],"evaluated":[12],"the":[13,75,93],"efficacy":[14],"and":[15,83,104,143,167],"tolerability":[16],"of":[17,53,77,90,111,150,163,169,180,191],"lamivudine":[18,48,103,123,183],"as":[19],"a":[20,41,187],"treatment":[21,181],"with":[25,33,147,174,182,186],"virus":[28],"(HBV)":[29],"children.":[31],"Children":[32],"were":[37,98],"randomly":[38,99],"assigned":[39,100],"2:1":[42],"ratio":[43],"to":[44,101,106,157],"receive":[45,102,107],"either":[46],"oral":[47],"(3":[49],"mg":[50],"per":[51],"kilogram":[52],"body":[54],"weight;":[55],"maximum,":[56],"100":[57],"mg)":[58],"or":[59],"placebo":[60,129],"once":[61],"daily":[62],"52":[64,89,116,178],"weeks.":[65],"The":[66,109],"primary":[67],"end":[68],"point":[69],"was":[70,117,140,144,184,195],"virologic":[71,112,192],"response":[72,113,193],"(defined":[73],"by":[74],"absence":[76],"serum":[78,84],"e":[81,155,160],"antigen":[82,156],"HBV":[85,170],"DNA)":[86],"at":[87,114],"week":[88,115],"treatment.":[91],"Of":[92],"403":[94],"children":[95,120,173],"screened,":[96],"191":[97],"97":[105],"placebo.":[108,196],"rate":[110,190],"higher":[118,148,189],"among":[119,125],"who":[121,127],"received":[122,128],"than":[124,194],"those":[126],"(23":[130],"percent":[131],"vs.":[132],"13":[133],"percent,":[134],"P":[135],"\u00bc":[136],"0.04).":[137],"well":[141],"tolerated":[142],"also":[145],"associated":[146,185],"rates":[149],"seroconversion":[151],"from":[152],"antibody,":[161],"normalization":[162],"alanine":[164],"aminotransferase":[165],"levels,":[166],"suppression":[168],"DNA.":[171],"In":[172],"B,":[177],"weeks":[179],"significantly":[188],"[N":[197],"Engl":[198],"J":[199],"Med":[200],"2002;346:1706\u20131713]":[201]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-07-22T00:00:00"}